Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness

Cancer Research

Volumn 56, Issue 6, 1996, Pages 1457-1465

  Lewis, Gail D ^a   Lofgren, Julie A ^a   McMurtrey, Amy E ^a   Nuijens, Andrew ^a   Fendly, Brian M ^a   Bauer, Kenneth D ^a   Sliwkowski, Mark X ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR;

ANTIBODY RESPONSE; ARTICLE; BREAST CANCER; CANCER GROWTH; CELL PROLIFERATION; COLONY FORMATION; DNA SYNTHESIS; GENE FREQUENCY; GENE MUTATION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; TRANSACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARRIER PROTEINS; CELL ADHESION; CELL COUNT; CELL CYCLE; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FEMALE; GLYCOPROTEINS; HUMANS; NEUREGULIN-1; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; TUMOR CELLS, CULTURED;

EID: 0029879442     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Prigent, S. A., and Lemoine, N. R. The type 1 (EGFR-related) family of growth factor receptors and their ligands Progress Growth Factor Res., 4- 1-24, 1992.
2. Harris, S. R., Lippman, M. E , Veronesi, U , and Willen, W. Breast cancer. N. Engl J. Med , 327: 473-480, 1992
3. Hynes, N. E. Amplification and overexpression of the erbB-1 gene in human tumors, its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Semm. Cancer Biol., 4: 19-25, 1993.
4. Modjtahedi, H , and Dean, C. The receptor for EGF and its ligands: expression, prognostic value and target for therapy. Int. J. Oncol., 4: 277-296, 1994.
5. Baselga, J., and Mendelsohn, J. Receptor blockade with monoclonal antibodies as anti-cancer therapy. Pharmacol. & Ther., 64: 127-154, 1994.
6. Radinsky, R., Risin, S., Fan, D., Dong, Z., Bielenberg, D., Bucana, C. D., and Fidler, I. J. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res., 1: 19-31, 1995
7. Scher, H. I., Sarkis, A., Reuter, V., Cohen, D , Netto, G., Petrylak, D., Lianes, P., Fuks, Z., Mendelsohn, J , and Cordon-Cardo, C. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms. Clin Cancer Res., 1: 545-550, 1995.
8. Lee, J , and Wood, W. I. Assignment of heregulin (HGL) to human chromosome 8p22-p11 by PCR analysis of somatic cell hybrid DNA Genomics. 16: 790-791, 1993
9. Orr-Urtreger, A , Trakhtenbrot, L., Ben-Levy, R , Wen, D , Rechavi, G., Lonai, P. and Yarden, Y. Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21. Proc. Natl Acad. Sci. USA, 90: 1867-1871, 1993.
10. crbB2 Science (Washington DC). 256: 1205-1210, 1992.
11. Peles, E., Bacus, S. S., Koski, R. A , Lu, H. S., Wen, D., Ogden, S. G., Levy, R. B , and Yarden, Y Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells Cell. 69: 205-216, 1992.
12. Wen, D., Peles, E., Cupples, R , Suggs, S. V., Bacus, S. S., Luo, Y , Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., Ben Levy, R., Koski, R. A., Lu, H S., and Yarden, Y Neu differentiation factor: a rransmembrane glycoprotein containing an EGF domain and an immunoglobuun homology unit Cell, 69: 559-572, 1992.
13. crbB2. Science (Washington DC), 249: 1552-1555, 1990.
14. Lupu, R., and Lippman, M. E. The role of erbB2 signal transducuon pathways in human breast cancer. Breast Cancer Res Treat., 27 83-93, 1993.
15. Falls, D L , Rosen, K M., Corfas, G., Lane, W. S., and Fischbach, G. D. ARIA, a protein that stimulates acetylcholme receptor synthesis, is a member of the neu ligand family. Cell, 72: 801-815, 1993.
16. Marchionni, M. A., Goodearl, A D., Chen, M. S , Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D , Lynch, C , Baldassare, M., Hiles, I., Davis, J B., Hsuan, J. J., Torty, N. F. Otsu, M., McBurney, R. N., Waterfield, M D , Stoobant, P., and Gwynne, D. Ghal growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature (Lond.), 362. 312-318, 1993.
17. Ho, W-H., Armanini, M. P., Nuijens, A., Phillips, H. S , and Osheroff, P. L. SMDF, a novel heregulin isoform hishly expressed in sensory and motor neurons. J. Biol. Chem., 270: 14523-14532, 1995.
18. Carraway, K. L., and Cantley, L. C. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell, 78: 5-8, 1994.
19. Earp, H. S., Dawson, T. L., Li, X., and Yu, H. Heterodimenzation and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat, 35: 115-132, 1995.
20. Kaninagaran, D., Tzahar, E. Liu, N., Wen, D., and Yarden, Y. Neu differentiation factor inhibits EGF binding: a model for trans-regulation within the ErbB family of receptor tyrosine kinases. J. Biol. Chem., 270: 9982-9990, 1995.
21. Levi, A. D., Bunge, R. P., Lofgren, J. A., Meima, L., Hefri, F., Nikolics, K., and Sliwkowski, M. X. The influence of heregulins on human Schwann cell proliferation. J. Neurosci., 15: 1329-1340, 1995
22. Graus-Porta, D., Beerli, R. R., and Hynes, N. E. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol., 15: 1182-1191, 1995.
23. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
24. Slamon, D. J , Godolphin, W , Jones, L. A , Holt, J A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989.
25. Hynes, N E., and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer Biochim. Biophys. Acta. 1198: 165-184, 1994.
26. Bacus, S. S., Huberman, E., Chin, D , Kiguchi, K., Simpson, S , Lippman, M., and Lupu, R. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells Cell Growth & Differ., 3: 401-411, 1992.
27. HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol., 9: 1165-1172, 1989
28. Fendly, B. M., Winget M., Hudziak, R. M., Lipari, M. T , Napier, M. A , and Ullrich, A. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res. 50: 1550-1558, 1990
29. Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A , Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L. and Carraway, K L Coexpression of erbB2 and ertB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem., 209: 14661-14665, 1994.
30. HER2 monoclonal antibodies. Cancer Immunol. Immunother., 37: 255-263, 1993.
31. Carraway, K. L , Sliwkowski, M. X., Akita, R., Platko, J. V., Guy, P M., Nuijens, A., Diamonu, A. J., Vandlen, R. L., Cantley, L. C., and Cerione, R. A. The erbB3 gene product is a receptor for heregulin. J. Biol. Chem., 269: 14303-14306, 1994.
32. Carraway, K. L., Soltoff, S. P , Diamonti, A. J., and Cantley, L. C. Heregulin stimulates autogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J. Biol. Chem., 270: 7111-7116, 1995.
33. Tzahar, E., Levkowitz, G., Kaninagaran, D., Yi, L., Peles, E , Lavi, S , Chang, D., Liu, N., Yayon, A., Wen, D., and Yarden, Y. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J. Biol. Chem., 269: 25226-25233, 1994
34. Jeschke, M., Wels, W., Dengler, W., Imber, R., Stocklin, E., and Groner, B. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins. Int J. Cancer. 60. 730-739, 1995.
35. Plowman, G. D., Culouscou, J M., Whitney, G. S , Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., and Shoyab, M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA, 90: 1746-1750, 1993.
36. Kraus, M. H., Fedi, P., Starts, R., Muraro, R., and Aaronson, S. A. Demonstration of ligand-dependent signaling by the erbB-3 tyrosme kinase and its constitutive activation in human breast tumor cells. Proc. Natl Acad. Sci. USA, 90: 2900-2904, 1993.
37. Scott, G. K., Robles, R., Park, J W., Montgomery, P. A., Daniel, J., Holmes, W. E., Lee, J., Keller, G. A., Li, W. L., Fendly, B. M., Wood, W. I., Shepard, H. M., and Benz, C. C. A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol. Cell. Biol., 13: 2247-2257, 1993.
38. Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., and King, C. R. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J., 6: 605-610, 1987.
39. Davidson, N. E., Gelmann, E. P., Lippman, M. E , and Dickson, R E Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol., 1: 216-223, 1987.
40. Read, L. D., Keith, D , Jr, Slamon, D. J., and Kauenellenbogen, B. S. Hormonal modulatron of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res., 50: 3947-3951, 1990.
41. Ram, T. G., Kokeny, K. E., Dilts, C. A., and Ethier, S. P. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-1 in human mammary epithelial cells. J. Cell. Physiol., 163: 589-596, 1995.
42. Pietras, R. J , Arboleda, J., Reese, D M., Wongvipat, N., Pegram, M. D., Rarnos, L , Gorman, C. M. Parker, M. G., Sliwkowski, M. X., and Slamon, D. J. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells Oncogene, 10: 2435-2446, 1995.
43. Filmus, J., Pollak, M. N., Cailleau, R., and Buick, R. N. MDA-468, a human breast cancer cell line with high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by egf Biochem. Biophys. Res. Commun., 128. 898-905, 1985.
44. Gill, G. N , and Lazar, C. S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature (Lond.), 295. 305-307, 1981.
45. Barnes, D W Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture. J. Cell Biol., 93: 1-4, 1982.
46. Bacus, S. S., Gudkov, A. V., Zelnick, C. R., Chin, D., Stern, R., Stancovski, I , Peles, E., Ben-Baruch, N , Farbstein, H., Lupu, R., Wen, D., Sela, M., and Yarden, Y Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: imphcalions for mammary tumors. Cancer Res., 53 5251-61, 1993.
47. crbB3 possesses an impaired tyrosine kinase activity. Proc Natl. Acad. Sci. USA, 91: 8132-8136, 1994.
48. Kim, H. H., Sierke, S L., and Koland, J. G. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. J. Biol. Chem., 269: 24747-24755, 1994
49. Soltoff, S. P., Carraway, K. L , Prigent, S. A., Gullick, W. G., and Cantley, L. C. ErbB3 is involved in activation of phosphatidylmositol 3-kinase by epidermal growth factor. Mol. Cell. Biol., 14: 3550-3558, 1994.
50. Plowman, G. D., Green, J. M., Culouscou, J. M., Cariton, G. W., Rothwell, V. M , and Buckley, S Heregulin induces tyrosine phosphorytauon of HER4/p180erbB4. Nature (Lond.), 366: 473-475, 1993.
51. Gassmann, M., Casagranda, F., Onoli, D., Simon, H., Lai, C., Klein, R., and Lemke, G Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (Lond), 378. 390-394, 1995.
52. Beerli, R., Graus-Porta, D., Woods-Cook, K., Chen, X , Yarden, Y., and Hynes, N. E. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2 Mol. Cell. Biol., 15. 6496-6505, 1995.
53. Alimandi, M., Romaao, A., Cuna, M. C., Muraro, R , Fedi, P., Aaronson, S. A., Di Fiore, P. P., and Kraus, M. H. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas Oncogene, 10: 1813-1821, 1995.
54. White, M. F. The IRS-1 signaling system. Curr. Opin. Genet. Dev . 4: 47-54, 1994.
55. Wallasch, C., Weiss, F. U., Niederfellner, G., Jallal, B , Issing, W., and Ullrich, A. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14: 4267-4275, 1995.
56. Marte, B. M., Jeschke, M., Graus-Porta, D., Taverna, D., Hofer, P., Groner, B., Yarden, Y., and Hynes, N. E. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Mol. Endocrinol., 9: 14-23, 1995
57. Marte, B M , Graus-Porta, D., Jeschke, M., Fabbro, D., Hynes, N. E., and Taverna, D. NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene, 10: 167-175, 1995.
58. 3H]thymidine techniques to measure cell proliferation Cell Tissue Kinet. 14: 111-120, 1981.
59. 3H]thymidine incorporation into DNA as an indicator of epidermal keratinocyte proliferation in vitro Cell Tissue Kinet., 12: 605-614, 1979.
60. 3H-thymidine incorporation but not on proliferation of breast cancer cultured cells. Cell Tissue Kinet., 18: 457-464, 1985.
61. Chazin, V. R., Kaleko, M., Miller, A D., and Slamon, D. J. Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor. Oncogene. 7: 1859-1866, 1992.
62. Ginsburg, E., and Vonderhaar, B K. Epidermal growth factor stimulates the growth of A431 tumours in athymic mice. Cancer Lett. 28: 143-150, 1985.
63. Ozawa, S., Ueda, M , Ando, N., Abe, O., Hirai, M., and Shimizu, N. Stimulation by EGF of the growth of EGF receptor-hyperproducmg tumour cells in athymic mice. Int. J. Cancer. 40: 706-710, 1987
64. Park, J. W , Slamon, D , and Shepard, H. M. Loss of heregulin expression is associated with malignancy. Proc. Am. Assoc. Cancer Res., 84- 3107, 1993.